BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15294447)

  • 21. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y; Harel-Orbital T; Gaffield W; Liscovitch M
    Anticancer Res; 2001; 21(2A):1189-94. PubMed ID: 11396162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance.
    Chanmahasathien W; Ampasavate C; Greger H; Limtrakul P
    Phytomedicine; 2011 Jan; 18(2-3):199-204. PubMed ID: 20739156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
    Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver.
    Arora A; Seth K; Shukla Y
    Carcinogenesis; 2004 Jun; 25(6):941-9. PubMed ID: 14729595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA; Ghetie V; Vitetta ES
    Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells.
    Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH
    J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
    Wang Y; Georges E
    Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Ji BS; Li M; He L
    Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells.
    Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK
    Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mode of action of torilin in multidrug-resistant cancer cell lines.
    Kim SE; Hong YS; Kim YC; Lee JJ
    Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine.
    Jin J; Wang FP; Wei H; Liu G
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Assef Y; Rubio F; Coló G; del Mónaco S; Costas MA; Kotsias BA
    Leuk Res; 2009 May; 33(5):710-6. PubMed ID: 18977528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.
    Ma Y; Wink M
    Phytomedicine; 2008 Sep; 15(9):754-8. PubMed ID: 18222670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.
    Susa M; Choy E; Yang C; Schwab J; Mankin H; Hornicek F; Duan Z
    J Biomol Screen; 2010 Mar; 15(3):287-96. PubMed ID: 20150589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
    Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
    Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
    Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
    Zhao Y; Bu L; Yan H; Jia W
    Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS; Thimmaiah P; Thimmaiah KN
    Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.